Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.74+0.05 (+1.86%)
Close on Nov 19, 2026Market cap $117.68MP/E –Yield –
Pulmonx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Pulmonx's gross profit for the twelve months ending Jun 30, 2026 was $67.38M, up 1.8% year over year. For fiscal 2025 it was $67.14M, up 8.3% from the year before. The highest annual figure on record is $67.14M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.14M | +8.3% |
| FY2024 | Dec 31, 2024 | $62.00M | +22.2% |
| FY2023 | Dec 31, 2023 | $50.75M | +27.3% |
| FY2022 | Dec 31, 2022 | $39.87M | +11.9% |
| FY2021 | Dec 31, 2021 | $35.63M | +68.1% |
| FY2020 | Dec 31, 2020 | $21.20M | -5.4% |
| FY2019 | Dec 31, 2019 | $22.41M | +82.4% |
| FY2018 | Dec 31, 2018 | $12.29M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.74M | +3.1% |
| Q1 FY2026 | Mar 31, 2026 | $16.04M | -1.8% |
| Q4 FY2025 | Dec 31, 2025 | $17.54M | -0.3% |
| Q3 FY2025 | Sep 30, 2025 | $16.05M | +6.8% |
| Q2 FY2025 | Jun 30, 2025 | $17.20M | +12.4% |
| Q1 FY2025 | Mar 31, 2025 | $16.34M | +16.1% |
| Q4 FY2024 | Dec 31, 2024 | $17.59M | +22.2% |
| Q3 FY2024 | Sep 30, 2024 | $15.03M | +15.3% |
| Q2 FY2024 | Jun 30, 2024 | $15.31M | +20.2% |
| Q1 FY2024 | Mar 31, 2024 | $14.08M | +32.9% |
| Q4 FY2023 | Dec 31, 2023 | $14.40M | +28.8% |
| Q3 FY2023 | Sep 30, 2023 | $13.03M | +28.3% |
| Q2 FY2023 | Jun 30, 2023 | $12.73M | +22.2% |
| Q1 FY2023 | Mar 31, 2023 | $10.59M | +30.6% |
| Q4 FY2022 | Dec 31, 2022 | $11.18M | +9.1% |
| Q3 FY2022 | Sep 30, 2022 | $10.15M | +4.2% |
| Q2 FY2022 | Jun 30, 2022 | $10.42M | +15.4% |
| Q1 FY2022 | Mar 31, 2022 | $8.11M | +22.7% |
| Q4 FY2021 | Dec 31, 2021 | $10.25M | +44.8% |
| Q3 FY2021 | Sep 30, 2021 | $9.74M | +30.5% |
| Q2 FY2021 | Jun 30, 2021 | $9.03M | +792.2% |
| Q1 FY2021 | Mar 31, 2021 | $6.61M | +17.0% |
| Q4 FY2020 | Dec 31, 2020 | $7.08M | -3.5% |
| Q3 FY2020 | Sep 30, 2020 | $7.46M | +16.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.01M | -79.6% |
| Q1 FY2020 | Mar 31, 2020 | $5.65M | +52.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.34M | – |
| Q3 FY2019 | Sep 30, 2019 | $6.41M | – |
| Q2 FY2019 | Jun 30, 2019 | $4.95M | – |
| Q1 FY2019 | Mar 31, 2019 | $3.72M | – |
See a number that looks wrong?